Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Infographic
Sep 17, 2018
| Erica Klinger
Generic Drugs Are the Prescription for Savings. Here’s Why You Shouldn’t Take Them for Granted.
Fact Sheet
Sep 17, 2018
| Erica Klinger
How a Renegotiated NAFTA Could Keep Drug Prices High for Patients
Blog
Sep 13, 2018
| Rachel Schwartz
Recap: Highlights From the First GRx+Biosims Conference
Video
Sep 12, 2018
| Erica Klinger
Ariel's Story – Savings from Generic Medicines
Press Release
Sep 4, 2018
| Rachel Schwartz
New Study Finds Patients, Government and Insurance Lose $13.4B in Potential Savings By Brand Drug Companies’ Abuses
Blog
Aug 30, 2018
| Jewel Smith
Four Reasons Why – The Benefits of AAM Membership
Press Release
Aug 28, 2018
| Rachel Schwartz
North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics
Infographic
Aug 16, 2018
| Erica Klinger
Prescription Drug Education Saves Lives and Dollars Infographic
Video
Aug 16, 2018
| Erica Klinger
Overview of the EverFi Prescription Drug Abuse Prevention Digital Course
Video
Aug 16, 2018
| Allen Goldberg
EverFi Opioid Abuse Prevention Education Program — underwritten by AAM
Video
Aug 14, 2018
| Erica Klinger
Christine Simmon: GRx+Biosims Combines Three Events into One
Press Release
Aug 8, 2018
| Rachel Schwartz
AAM Statement in Response to FDA's Competitive Generic Therapy (CGT) Designation
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action